Form 4: Trulieve Cannabis Corp. Executive Timothy Morey Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Trulieve Cannabis Corp.'s Chief Sales Officer, Timothy Morey, was granted stock options and restricted stock units (RSUs) according to a recent SEC filing.
Summary
- Timothy Morey, Chief Sales Officer of Trulieve Cannabis Corp., received a grant of 33,000 restricted stock units (RSUs) on March 8, 2024.
- These RSUs represent a contingent right to receive Trulieve Cannabis Corp. subordinate voting shares.
- 50% of the RSUs will vest on December 1, 2025, and the remaining 50% will vest on December 1, 2026.
- Morey also received stock options for 59,754 subordinate voting shares with an exercise price of $10 on March 8, 2024.
- The options become exercisable in three annual installments, vesting on December 1, 2024, December 1, 2025, and December 1, 2026.
- Following these transactions, Morey directly owns 113,266 subordinate voting shares and 59,754 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of equity to a key executive is generally a positive sign, indicating confidence in the company's future performance and aligning management's interests with shareholders.
Positives
- The grant of RSUs and stock options to the Chief Sales Officer aligns his interests with those of the shareholders.
- The vesting schedules for both the RSUs and stock options encourage long-term commitment from the executive.
Industry Context
Grants of stock options and restricted stock units are common practices in the cannabis industry to attract and retain key executives, aligning their interests with the long-term success of the company.
Comparison to Industry Standards
- Stock option and RSU grants are a typical component of executive compensation packages in the cannabis industry, similar to companies like Curaleaf, Green Thumb Industries, and Canopy Growth.
- The vesting schedules are also fairly standard, designed to incentivize long-term performance and retention.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
- Employees may be motivated by the fact that key executives are incentivized to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of grant for RSUs and stock options |
| 12/01/2024 | First vesting date for one-third of the stock options |
| 12/01/2025 | First vesting date for 50% of the RSUs and second vesting date for one-third of the stock options |
| 12/01/2026 | Final vesting date for the remaining 50% of the RSUs and the final one-third of the stock options |
| 03/08/2031 | Expiration date of the stock options |
| 03/12/2024 | Date of filing of the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.